Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Spirulina Market by Distribution Channel, Product Type, Application - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The spirulina market is expected to record a CAGR of 13.2% from 2021 to 2028 to reach $968.6 million by 2028. In terms of volume, the spirulina market is expected to register a CAGR of 18.1% from 2021 to 2028 to reach 98,768.5 tons by 2028. The factors such as growing health & wellness trends and dietary supplements industry; growing demand for natural food colors; increasing vegetarianism; stringent regulations regarding the inclusion of synthetic colors and flavors; growing malnutrition; increasing preference for spirulina sourced products, especially omega-3 fatty acids; growing use of spirulina in aquaculture; growing investments from leading color houses, and increase in number of products that include spirulina as ingredients are driving the growth in the global spirulina market. However, low awareness about the benefits of spirulina and challenges associated with spirulina production is expected to hinder the growth of the global spirulina market to some extent. The global spirulina market study presents historical market data in terms of values and volumes (2019 and 2020), estimated current data (2021), and forecasts for 2028- by distribution channel (consumer channel, business channel), product type (powder, tablets, capsules, flakes, phycocyanin extract, and frozen spirulina), and application (nutraceuticals, food & beverages, animal feed, cosmetics, and agriculture). The study also evaluates industry competitors and analyzes the market at a regional and country level. Based on the distribution channel, the spirulina market is mainly segmented into consumer and business channels. In 2021, the business channel segment is estimated to account for the largest share of the overall spirulina market. The largest share of this segment is mainly attributed to the direct purchase of bulk spirulina in large quantities by various manufacturers such as nutraceuticals, food and beverages, and animal feed, among others, for further product development. Based on the product type, the spirulina market is mainly segmented into powder, tablets, capsules, flakes, phycocyanin extracts, and frozen spirulina. The phycocyanin extracts segment is expected to grow with the fastest CAGR during the forecast period, attributed to factors such as tremendous demand from the food and beverage industry, where it is used as a natural food colorant; growing investment from leading players; and expanding application areas of phycocyanin.

However, the nutraceuticals segment is estimated to account for the largest share of the overall spirulina market in 2021. The largest share of this segment is attributed to the booming nutraceutical sector, growing health concerns of the aging population in various countries, growing desire for natural alternatives to traditional pharmaceutical products, and increased awareness among consumers on the link between nutrition and health. Based on application, in 2021, the nutraceuticals segment is estimated to account for the largest share of the overall spirulina market. The largest share of this segment is mainly attributed to the booming nutraceutical sector, growing health concerns of the aging population in various countries, growing desire for natural alternatives to traditional pharmaceutical products, and increased awareness among consumers on the link between nutrition and health.

An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2021, North America is estimated to account for the largest share of the spirulina market, followed by Asia-Pacific and Europe.

The large share of this region is mainly attributed to huge consumption of health supplements, strict regulations against the use of synthetic colors, growth of subsidiary industries like cosmetics and biofertilizers, increasing preference for natural protein sources, and presence of key spirulina manufacturers with huge production capacities.

1. Introduction 2. Research Methodology 3.Executive Summary 4. Industry Trends 4.1. Introduction 4.2. Spirulina Formulation 4.2.1. Recommended Daily Dose of Spirulina 4.3. Common Formulations of Spirulina 4.4. Value Chain Analysis 4.4.1. List of Key Producers, by Size 4.4.1.1. Microfarmers (< 2 Ton/Year) 4.4.1.2. Small Farmers (2-20 Ton/Year) 4.4.1.3. Large Farmers (20-200 Ton/Year) 4.4.1.4. Very Large Farmers (More than 200 Ton/Year) 4.4.2. Handling and Packaging Companies 4.4.3. List of Some of the Key Buyers 4.4.4. Pricing Analysis 5. Market Insights 5.1. Introduction 5.2. Drivers 5.2.1. Growing Health & Wellness Trends and Dietary Supplements Industry 5.2.2. Growing Demand for Natural Food Colours 5.2.3. Growing Vegetarianism 5.2.4. Positive Impact on Environment With Spirulina Cultivation 5.2.5. Strict Regulations Regarding the Inclusion of Synthetic Colors and Flavors 5.2.6. Growing Preference for Spirulina-Sourced Products 5.2.7. Growing Use of Spirulina in Aquaculture 5.2.8. Growing Investments from Natural-Color Manufacturers 5.3. Restraints 5.3.1. Low Awareness of Benefits of Spirulina 5.3.2. Complex Production of Algae Products 5.3.3. Risk of Contamination 5.4. Opportunities 5.4.1. Emergence of New Application Areas 5.4.2. Growing Demand for Phycocyanin 5.4.3. Growing Demand for Spirulina from Bio Refineries 5.4.4. Increasing Demand for Fresh/Frozen Spirulina 5.5. Trends 5.5.1. Adoption of New Production Technologies (Photobioreactors) 5.6. Standards and Regulations 5.6.1. Spirulina estimated Daily Intake 5.7. Force Field Analysis 6. The Impact of Covid-19 on the Spirulina Market 7. Global Spirulina Market, by Distribution Channel 7.1. Introduction 7.2. Business Channel 7.3. Consumer Channel 8. Global Spirulina Market, by Product Type 8.1. Introduction 8.2. Powder 8.3. Tablets 8.4. Capsules 8.5. Flakes 8.6. Phycocyanin Extracts 8.7. Frozen Spirulina 9. Global Spirulina Market, by Application 9.1. Introduction 9.2. Nutraceuticals 9.3. Food and Beverage 9.4. Animal Feed 9.5. Cosmetics 9.6. Agriculture 10. Global Spirulina Market, by Geography 11. Company Profiles 11.1. Microfarmers

Far East Microalgae Industries Co., Ltd (FEMICO)

Fuqing King Dnarmsa Spirulina Co.Ltd.

Earthrise Nutritionals, LLC (Part of DIC Corporation)

E.I.D. - Parry (India) Limited

Dongtai City Spirulina Bio-Engineering Co. Ltd.

Yunnan Green A Biological Project Co., Ltd.

Zhejiang Comp Spirulina Co., Ltd.

Ordos Xinyuli Spirulina Industry Group Co., Ltd.

Qingdao Haizhijiao Biotechnology Co., Ltd.

Inner Mongolia Rejuve Biotech Co., Ltd.

Hainan Dic Aisheng Microalgae Co., Ltd.

Zhejiang Binmei Biotechnology Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/izp42p

The U.S. government may throw its weight (and its money) behind expanding lithium production tomorrow.

Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk posted in a Twitter thread on Monday advising followers to own “physical things” when inflation is high. In the tweet, Musk said “As a general principle, for those looking for advice from this thread, it is generally better to own physical things like a home or stock in companies you think make good products, than dollars when inflation is high. I still own & won’t sell my Bitcoin, Ethereum or Doge fwiw.” The biggest takeaway for some followers seems to ha

Americans may have more help in the fight to save for retirement after House passes bipartisan retirement legislation.

The SECURE Act 2.0 — a follow up to the 2019 bill that made myriad changes to the way Americans save for retirement — passed in the House this week, meaning that if it gets approved by the Senate it … Continue reading → The post Your 401(k) Could Soon Get a $10,000 Catch-up Boost appeared first on SmartAsset Blog.

Clinical-stage biopharmaceutical company Geron (NASDAQ: GERN) saw its shares jump 23.4% on Wednesday. Geron was last this high on Nov. 15, and it has a 52-week low of $0.99 and a 52-week high of $2.23. The stock jumped on the type of news that ordinarily might make it fall -- the company announced it was making a public offering of common stock to raise money.

The stock market finally took a break on Wednesday from its string of big wins. Wall Street remained hopeful for favorable resolutions on key issues like inflation and the war in Ukraine, but that didn't stop the Dow Jones Industrial Average (DJINDICES: ^DJI), Nasdaq Composite (NASDAQINDEX: ^IXIC), and S&P 500 (SNPINDEX: ^GSPC) from giving up some ground after an impressive rally over the past few weeks.

The FDA has issued a complete response letter (CRL) to Akebia Therapeutics Inc's (NASDAQ: AKBA) marketing application (NDA) for vadadustat for anemia due to chronic kidney disease (CKD). Vadadustat is an investigational oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor. The FDA issues a CRL to indicate that the review cycle for an application is complete and that the application is not ready for approval in its present form. The FDA concluded that the data in the marketing appl

We all know how the stock market started out 2022 with a sudden reversal of last year’s bull run. By the end of February, it was clear that stocks had entered correction territory; the sell-off was broad-based, across all segments of the market. But is the sell-off over? There are indications that may be the case. Since bottoming out on March 14, the market has staged a strong rebound, and year-to-date is no longer in correction territory. The S&P 500 is up 10% in that period, and the NASDAQ, wh

Even with the economic reopening, the home improvement retailer's fundamentals are still robust.

Russian oil tankers have been disappearing from tracking systems. Someone is buying that crude and figuring out who is difficult.

Jim Cramer says not every company can pull off the transition from cyclical to secular growth stock.

There was no bad news for Nvidia specifically -- but the good news wasn't all that great. Take semiconductors peer company Micron (NASDAQ: MU) for example. Micron reported a big earnings beat for its second quarter of fiscal 2022 last night, and guided investors to expect another beat in the third quarter.

‘He tells me this is a great deal for me, as I am protected because of the equity in the house, and that I’m earning 5% on my money.’

The Dow Jones moved higher amid positive Russia-Ukraine cease-fire talks. Visa and Nike stock impressed. Robinhood stock exploded.

Investors are reacting to better than expected clinical trial results for its COVID-19 treatment candidate.

On March 28, Tesla announced that it will split its stock for the second time in two years. The decision also follows similar plans from Amazon and Google parent company Alphabet to do 20-for-1 stock splits, drastically lowering their respective share price. If approved, Amazon stock will drop from about $3300 to $165 while Alphabet will drop from about $2800 to $140.

Apple's stock has been rocking of late. Here's why.

Shares of AMC Entertainment Holdings (NYSE: AMC) look like they're about to break their winning streak as shares are down 6.1% at 1:22 p.m. ET. Of course, it looked that way yesterday, too, as the stock had stumbled out of the gate and trading in its shares were halted by the New York Stock Exchange after it triggered a circuit breaker. Once trading resumed, AMC's stock quickly reversed course and it ended the day $0.11 per share higher.

The Fed hike has raised mortgage rates and hitting credit cards. But when will high-yield savings accounts see the gains?

(Bloomberg) -- With all the focus on the risk of default by Russia, an even more spectacular collapse has gone largely unnoticed right next door: There’s a bond crisis brewing in Belarus, which has the world’s worst-performing government debt this year.Most Read from BloombergUkraine Update: U.S. Skeptical After Russia Vows Kyiv PullbackUkraine Update: Kyiv Seeks Cease-Fire Deal in Russia TalksAbramovich Suffered Suspected Poisoning During Ukraine TalksWorld’s Longest Passenger Flight Plans to A